How would you manage a patient with p53 mutated MCL who has progressed after a BTKi and CAR-T with a CD20 negative clone?
1 Answer
Mednet Member
Medical Oncology · CompHealth
Answered on
Venetoclax + CD19 or CD22 mab if available
Join for free or sign in to see the full answer